Prior treatment with oxaliplatin-containing regimens and higher total bilirubin levels are risk factors for neutropenia and febrile neutropenia in patients with gastric or esophagogastric junction cancer receiving weekly paclitaxel and ramucirumab therapy: a single center retrospective study

Autor: Nara, Katsuhiko1 (AUTHOR) knaratky@yahoo.co.jp, Yamamoto, Takehito1,2 (AUTHOR), Yamashita, Hiroharu3 (AUTHOR), Yagi, Koichi3 (AUTHOR), Takada, Tappei1 (AUTHOR), Seto, Yasuyuki3 (AUTHOR), Suzuki, Hiroshi1 (AUTHOR)
Zdroj: BMC Cancer. 10/13/2023, Vol. 23 Issue 1, p1-9. 9p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje